4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-017750
Chairman and CEO bought 42,850 shares at an average $1.44 ($61,896)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-03-06 | Purchase | +27,500 | $1.45 | $39,875 | 10,459,793 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-09 | Purchase | +11,600 | $1.31 | $15,196 | 10,471,393 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-10 | Purchase | +3,750 | $1.82 | $6,825 | 10,475,143 | D |
| Open-market purchases · 42,850 sh · avg $1.44 · $61,896 | |||||||
Loading xslF345X03/doc4.xml…